Climb Bio presents initial Phase 2 data for budoprutug in primary membranous nephropathy at ASN Kidney Week

Climb Bio presented initial Phase 2 data for budoprutug in primary membranous nephropathy at ASN Kidney Week 2026, adding to a series of kidney disease pipeline updates shared at the meeting.

Detected & updated continuously · Source: Nebula

Story subjects

Climb Bio, Inc.budoprutugASN Kidney Week 2026

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula